Skip to content

Point embedding therapy'sintervention effect on chronic obstructive pulmonary disease at stable stage in community

Point embedding therapy'sintervention effect on chronic obstructive pulmonary disease at stable stage in community

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16009927
Enrollment
Unknown
Registered
2016-11-19
Start date
2017-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease at stable stage

Interventions

COPD patients control group:conventional wester medicine treatment
COPD patients embedding group:conventional wester medicine treatment &Point embedding therapy
COPDhigh risk population control group :conventional wester medicine treatment
COPD high risk population embedding group:conventional wester medicine treatment &Point embedding therapy

Sponsors

Yueyang Hospital of Integrative Chinese & Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Conform to the western medicine diagnostic criteria, FEV1/FVC<70%, COPD patients at stable stage; FEV1/FVC =70%, COPD high risk population

Exclusion criteria

Exclusion criteria: (1) Chronic cough caused by Bronchial asthma, Bronchiectasis, Bronchial tumor, Tuberculosis, fungi, Excitant gas & allergy; (2) COPD with serious Cardiovascular, Liver, Kidney, Hematopoietic system & Mental disease; (3) Pregnant and lactational women; (4) Taking part in other drug test.

Design outcomes

Primary

MeasureTime frame
Symptom score;AECOPD attack number of times;FEV1;MSP;SGRQ;

Secondary

MeasureTime frame
BMI;MRC;6MW;TNF-a;IL-8;IL-6;

Countries

China

Contacts

Public ContactYao Liang

Yueyang Hospital of Integrative Chinese & Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine

yaoliangxmr@163.com+86 18930560239

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026